No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 16 of the 40 quarters in the window, leaving 24 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 3.1x · 10Y median 4.0x · 24th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T20:08:10.126Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T20:08:10.126Z. Latest historical point 2026-10-05.
EV/EBITDA and cash-flow multiples are withheld until their applicability to this financial-services business is verified. The lenses that apply are shown above; see also P/B and ROE.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T20:08:10.126Z. Latest historical point 2026-10-05.
EBITDA and cash-flow yields are withheld until their applicability to this financial-services business is verified. Earnings yield is shown above; see also P/B and ROE.
The latest delayed quote for PhenixFIN Corporation (PFX) stock was $44.59 as of Oct 6, 2026, 3:59 PM EDT, down 0.62% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -5.9% · 3-year avg +8.6%/yr · 5-year avg +2.2%/yr
PhenixFIN Corporation functions as a Business Development Company (BDC), concentrating its investment efforts on privately arranged debt and equity instruments issued by small and mid-sized businesses. The firm's primary geographical focus is North America.
Asset Management · New York City, NY
Next Earnings Date
Dec 11, 2026
66 days away
EPS Estimate
0.60
Revenue Est.
$5.80M
Last Quarter Results
EPS
$1.07
vs Estimate
$0.47
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1PFX | $86.17M | $44.59 | -0.62% | -5.89% | +2.17% | -8.03% | N/A |
| 2AUC | $86.32M | $8.37 | -0.95% | N/A | N/A | -4.66% | vs PFX |
| 3RNAQ | $86.60M | $10.04 | +0.00% | N/A | N/A | N/A | vs PFX |
| 4BCIC | $85.65M | $6.92 | +0.73% | -32.17% | -10.80% | -6.02% | vs PFX |
| 5PLCI | $85.39M | $9.90 | -0.20% | N/A | N/A | N/A | vs PFX |
| 6PECE | $87.20M | $9.98 | -0.20% | N/A | N/A | N/A | vs PFX |
TTM
3.15
$6.45M
vs Estimate
$5.63M
Consensus Rating
Average Price Target
N/A
Low
N/A
Current
$44.59
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.60 | $0.60 | $0.60 | 1 |
| Quarter ending Dec 2026 | $0.61 | $0.61 | $0.61 | 1 |
| Quarter ending Mar 2027 | $0.63 | $0.63 | $0.63 | 1 |
| Quarter ending Jun 2027 | $0.63 | $0.63 | $0.63 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $3.12 | $3.12 | $3.12 | 1 |
| FY 2027 | $2.52 | $2.52 | $2.52 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $5.80M | $5.80M | $5.80M | 1 |
| Quarter ending Dec 2026 | $5.80M | $5.80M | $5.80M | 1 |
| Quarter ending Mar 2027 | $5.80M | $5.80M | $5.80M | 1 |
| Quarter ending Jun 2027 | $5.80M | $5.80M | $5.80M | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Sep 30, 2027, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $24.11M | $24.11M | $24.11M | 1 |
| FY 2027 | $23.21M | $23.21M | $23.21M | 1 |
